Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Nuvve Holding (NVVEW) Research & Development (2020 - 2025)

Historic Research & Development for Nuvve Holding (NVVEW) over the last 6 years, with Q3 2025 value amounting to $1.2 million.

  • Nuvve Holding's Research & Development rose 6602.89% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 3181.52%. This contributed to the annual value of $4.5 million for FY2024, which is 4817.05% down from last year.
  • Per Nuvve Holding's latest filing, its Research & Development stood at $1.2 million for Q3 2025, which was up 6602.89% from $1.1 million recorded in Q2 2025.
  • Over the past 5 years, Nuvve Holding's Research & Development peaked at $2.4 million during Q2 2023, and registered a low of $710291.0 during Q3 2024.
  • For the 5-year period, Nuvve Holding's Research & Development averaged around $1.6 million, with its median value being $1.7 million (2021).
  • In the last 5 years, Nuvve Holding's Research & Development surged by 15384.62% in 2021 and then crashed by 6902.23% in 2024.
  • Over the past 5 years, Nuvve Holding's Research & Development (Quarter) stood at $1.9 million in 2021, then grew by 0.29% to $2.0 million in 2022, then rose by 1.34% to $2.0 million in 2023, then tumbled by 61.26% to $767558.0 in 2024, then surged by 53.64% to $1.2 million in 2025.
  • Its Research & Development stands at $1.2 million for Q3 2025, versus $1.1 million for Q2 2025 and $883772.0 for Q1 2025.